KMT2A and central nervous system cancer: Two studies used modified U-87 glioma cells lines to characterize the role of the KMT2A-NOTCH regulatory cascade (Huang et al., 2017) and of RECQ1 Helicase (Vittori et al., 2017) in glioma proliferation.